Multiple Myeloma Clinical Trials in Atlanta, Georgia

28 studies are recruiting for multiple myeloma in Atlanta, Georgia right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies, page 2

  1. CAR T-cell Therapy in Patients With Renal Dysfunction

    This is a prospective, descriptive study designed to assess the feasibility of administering CAR T therapy among patients with moderate to severe renal impairment using dose adjusted lymphodepleting chemotherapy.

    Stage
    Phase 2
    Ages
    18 and older
    Site
    Caitlin Guzowski, Atlanta, Georgia
    Run by
    Northside Hospital, Inc.

    See if you can join NCT05909059 on ClinicalTrials.gov

  2. IDP-023 as a Single Agent and in Combination With Antibody Therapies in Patients With Advanced Hematologic Cancers

    This is an open label, Phase 1/2, first-in-human, multiple ascending dose, and dose-expansion study of IDP-023 administered as a single agent and in combination with or without interleukin-2 (IL-2), and with or without isatuximab, daratumumab or rituximab to evaluate the safety, tolerability and pr…

    Stage
    Phase 1
    Ages
    18 and older
    Site
    Emory University Hospital, Atlanta, Georgia
    Locations
    12 in total
    Run by
    Indapta Therapeutics, INC.

    See if you can join NCT06119685 on ClinicalTrials.gov

  3. A Study to Evaluate the Safety, PK/PD of (OriCAR-017) in Subjects With RR/MM - RIGEL Study

    The is a first clinical study for Oricell Therapeutics Inc. in the United States to evaluate the safety, PK, PD and preliminary efficacy of our anti-GPRC5D cell product (OriCAR-017) in subjects with relapsed/refractory multiple myeloma. RIGEL Study

    Stage
    Phase 1
    Ages
    18 to 75
    Site
    Northside Hospital, Atlanta, Georgia
    Run by
    OriCell Therapeutics Co., Ltd.

    See if you can join NCT06271252 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.